PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2
暂无分享,去创建一个
[1] Peter Nürnberg,et al. Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. , 2004, American journal of human genetics.
[2] I. Duncan,et al. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia , 2004, The Journal of cell biology.
[3] E. Jacobs,et al. Embryonic Expression of the Soma-Restricted Products of the Myelin Proteolipid Gene in Motor Neurons and Muscle , 2004, Neurochemical Research.
[4] J. Lupski,et al. Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. , 2004, Human molecular genetics.
[5] P. Wight,et al. Where, when and how much: regulation of myelin proteolipid protein gene expression , 2004, Cellular and Molecular Life Sciences CMLS.
[6] M. Fontès,et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease , 2004, Nature Medicine.
[7] J. Lupski,et al. Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations , 2004, Nature Genetics.
[8] J. Lupski,et al. Intestinal aganglionosis associated with the Waardenburg syndrome: report of two cases and review of the literature , 2003, Pediatric Surgery International.
[9] Siddharthan Chandran,et al. FGF-dependent generation of oligodendrocytes by a hedgehog-independent pathway , 2003, Development.
[10] R. Schiffmann,et al. Insertion of mutant proteolipid protein results in missorting of myelin proteins , 2003, Annals of neurology.
[11] M. Filbin,et al. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS , 2003, Nature Reviews Neuroscience.
[12] J. Lupski,et al. Molecular mechanisms for genomic disorders. , 2003, Annual review of genomics and human genetics.
[13] K. Nave,et al. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A) , 2003, Nature Medicine.
[14] E. Bongarzone,et al. Expression of soma-restricted proteolipid/DM20 proteins in lymphoid cells , 2003, Journal of Neuroimmunology.
[15] B. Popko. Notch signaling: a rheostat regulating oligodendrocyte differentiation? , 2003, Developmental cell.
[16] E. Jacobs,et al. Soma-Restricted Products of the Myelin Proteolipid Gene Are Expressed Primarily in Neurons in the Developing Mouse Nervous System , 2003, Developmental Neuroscience.
[17] Neal N. Iwakoshi,et al. Proteasome inhibitors disrupt the unfolded protein response in myeloma cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] John Q Trojanowski,et al. ‘Unfolding’ pathways in neurodegenerative disease , 2003, Trends in Neurosciences.
[19] S. Takashima,et al. Myelination of a fetus with Pelizaeus–Merzbacher disease: Immunopathological study , 2003, Annals of neurology.
[20] N. Niikawa,et al. Functional disomy for Xq22‐q23 in a girl with complex rearrangements of chromosomes 3 and X , 2003, American journal of medical genetics. Part A.
[21] J. Fink,et al. The hereditary spastic paraplegias: nine genes and counting. , 2003, Archives of neurology.
[22] S. High,et al. Role of calnexin in the glycan‐independent quality control of proteolipid protein , 2003, The EMBO journal.
[23] P. Ye,et al. Mouse NG2+ Oligodendrocyte Precursors Express mRNA for Proteolipid Protein But Not Its DM-20 Variant: A Study of Laser Microdissection-Captured NG2+ Cells , 2003, The Journal of Neuroscience.
[24] H. Moser,et al. Proton MR Spectroscopic Imaging in Pelizaeus-Merzbacher Disease , 2003, AJNR. American journal of neuroradiology.
[25] Angelo L. Vescovi,et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis , 2003, Nature.
[26] R. Winter,et al. Complex chromosomal rearrangement and associated counseling issues in a family with Pelizaeus‐Merzbacher disease , 2003, American journal of medical genetics. Part A.
[27] W. Macklin,et al. Proteolipid Protein Gene Mutation Induces Altered Ventilatory Response to Hypoxia in the Myelin-Deficient Rat , 2003, The Journal of Neuroscience.
[28] D. Sammond,et al. Normal metabolism but different physical properties of myelin from mice deficient in proteolipid protein , 2003, Journal of neuroscience research.
[29] E. Bertini,et al. Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy , 2003, Annals of neurology.
[30] K. Nave,et al. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination , 2003, Nature Genetics.
[31] J. Lupski,et al. Congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg–Hirschsprung disease: Phenotypes linked by SOX10 mutation , 2002, Annals of neurology.
[32] Wei Jiang,et al. The Unfolded Protein Response Modulates Disease Severity in Pelizaeus-Merzbacher Disease , 2002, Neuron.
[33] J. Garbern,et al. Prenatal diagnosis of Pelizaeus‐Merzbacher disease , 2002, Prenatal diagnosis.
[34] H. Marks,et al. A PLP splicing abnormality is associated with an unusual presentation of PMD , 2002, Annals of neurology.
[35] L. Shaffer,et al. Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females. , 2002, American journal of human genetics.
[36] M. Sospedra,et al. Multiple sclerosis candidate autoantigens except myelin oligodendrocyte glycoprotein are transcribed in human thymus , 2002, European journal of immunology.
[37] W. Macklin,et al. Myelin Proteolipid Protein Forms a Complex with Integrins and May Participate in Integrin Receptor Signaling in Oligodendrocytes , 2002, The Journal of Neuroscience.
[38] K. Yamakawa,et al. The Xq22 inversion breakpoint interrupted a novel Ras-like GTPase gene in a patient with Duchenne muscular dystrophy and profound mental retardation. , 2002, American journal of human genetics.
[39] I. Griffiths,et al. Survival of, and competition between, oligodendrocytes expressing different alleles of the Plp gene , 2002, The Journal of cell biology.
[40] I. Verma,et al. SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism , 2002, Human Genetics.
[41] J. Schulz,et al. Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes , 2002, The Journal of cell biology.
[42] Erik A Sistermans,et al. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. , 2002, Brain : a journal of neurology.
[43] R. Skoff,et al. Proteolipid Protein Gene Modulates Viability and Phenotype of Neurons , 2002, The Journal of Neuroscience.
[44] P. Stankiewicz,et al. Genome architecture, rearrangements and genomic disorders. , 2002, Trends in genetics : TIG.
[45] S. Tanada,et al. Brain N-acetylaspartate is elevated in Pelizaeus–Merzbacher disease with PLP1 duplication , 2002, Neurology.
[46] M. Wegner,et al. Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. , 2002, Genes & development.
[47] B. Trapp,et al. N‐acetylaspartate is an axon‐specific marker of mature white matter in vivo: A biochemical and immunohistochemical study on the rat optic nerve , 2002, Annals of neurology.
[48] L. Shaffer,et al. Compensating for central nervous system dysmyelination: Females with a proteolipid protein gene duplication and sustained clinical improvement , 2001, Annals of neurology.
[49] L. Shaffer,et al. Prenatal interphase FISH diagnosis of PLP1 duplication associated with Pelizaeus–Merzbacher disease , 2001, Prenatal diagnosis.
[50] W J Schwartz,et al. Towards the reconstruction of central nervous system white matter using neural precursor cells. , 2001, Brain : a journal of neurology.
[51] K. Nave,et al. Differential expression of apoptotic markers in jimpy and in Plp overexpressors: evidence for different apoptotic pathways , 2001, Journal of neurocytology.
[52] E. Le Guern,et al. The SOX10 transcription factor: evaluation as a candidate gene for central and peripheral hereditary myelin disorders , 2001, Journal of Neurology.
[53] R. Schiffmann,et al. Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations , 2001, Neurology.
[54] A. Gow,et al. Molecular Pathways of Oligodendrocyte Apoptosis Revealed by Mutations in the Proteolipid Protein Gene , 2022 .
[55] G. Fishell,et al. Sonic hedgehog contributes to oligodendrocyte specification in the mammalian forebrain. , 2001, Development.
[56] S. Malcolm,et al. The proteolipid protein gene and myelin disorders in man and animal models. , 2000, Human molecular genetics.
[57] B. Dastugue,et al. Genotype–phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations , 2000, European Journal of Human Genetics.
[58] I. D. de Coo,et al. Mutations in noncoding regions of the proteolipid protein gene in Pelizaeus–Merzbacher disease , 2000, Neurology.
[59] M. Simons,et al. Assembly of Myelin by Association of Proteolipid Protein with Cholesterol- and Galactosylceramide-Rich Membrane Domains , 2000, The Journal of cell biology.
[60] E. Zackai,et al. Additional copies of the proteolipid protein gene causing Pelizaeus-Merzbacher disease arise by separate integration into the X chromosome. , 2000, American journal of human genetics.
[61] K. Woodward,et al. X inactivation phenotype in carriers of Pelizaeus-Merzbacher disease: skewed in carriers of a duplication and random in carriers of point mutations , 2000, European Journal of Human Genetics.
[62] V. Friedrich,et al. The Evolution of Lipophilin Genes from Invertebrates to Tetrapods: DM-20 Cannot Replace Proteolipid Protein in CNS Myelin , 2000, The Journal of Neuroscience.
[63] Barkovich Aj. Concepts of Myelin and Myelination in Neuroradiology , 2000 .
[64] T. Holekamp,et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[65] A. Munnich,et al. Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain. , 2000, American journal of human genetics.
[66] T. Popolizio,et al. Proton MR spectroscopy in connatal Pelizaeus-Merzbacher disease , 2000, Pediatric Radiology.
[67] Joanne Chan,et al. Sonic Hedgehog–Regulated Oligodendrocyte Lineage Genes Encoding bHLH Proteins in the Mammalian Central Nervous System , 2000, Neuron.
[68] David J Anderson,et al. Identification of a Novel Family of Oligodendrocyte Lineage-Specific Basic Helix–Loop–Helix Transcription Factors , 2000, Neuron.
[69] C. ffrench-Constant,et al. Integrins mediate a neuronal survival signal for oligodendrocytes , 1999, Current Biology.
[70] J. Takanashi,et al. MR-revealed myelination in the cerebral corticospinal tract as a marker for Pelizaeus-Merzbacher's disease with proteolipid protein gene duplication. , 1999, AJNR. American journal of neuroradiology.
[71] E. Jacobs,et al. Identification of a New Exon in the Myelin Proteolipid Protein Gene Encoding Novel Protein Isoforms That Are Restricted to the Somata of Oligodendrocytes and Neurons , 1999, The Journal of Neuroscience.
[72] M. Shy,et al. The molecular pathogenesis of Pelizaeus-Merzbacher disease. , 1999, Archives of neurology.
[73] J. Lupski,et al. Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation , 1999, Annals of neurology.
[74] J. Boire,et al. Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher Disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. The Clinical European Network on Brain Dysmyelinating Disease. , 1999, American journal of human genetics.
[75] R. McKay,et al. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. , 1999, Science.
[76] T. Ozawa,et al. A de novo splice donor site mutation causes in‐frame deletion of 14 amino acids in the proteolipid protein in Pelizaeus‐Merzbacher disease , 1999, Annals of neurology.
[77] L. Shaffer,et al. Proteolipid protein gene duplications causing Pelizaeus‐Merzbacher disease: Molecular mechanism and phenotypic manifestations , 1999, Annals of neurology.
[78] J. Nagle,et al. Novel exon 3B proteolipid protein gene mutation causing late‐onset spastic paraplegia type 2 with variable penetrance in female family members , 1999, Annals of neurology.
[79] K. Woodward,et al. Prenatal diagnosis by FISH in a family with Pelizaeus–Merzbacher disease caused by duplication of the PLP gene , 1999 .
[80] R. Skoff,et al. Programmed cell death without DNA fragmentation in the jimpy mouse: secreted factors can enhance survival , 1999, Cell Death and Differentiation.
[81] I. Kanazawa,et al. Pelizaeus‐Merzbacher disease: Three novel mutations and implication for locus heterogeneity , 1999, Annals of neurology.
[82] I. Duncan,et al. Myelin mosaicism and brain plasticity in heterozygous females of a canine X‐linked trait , 1998, Annals of neurology.
[83] J. Lupski. Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. , 1998, Trends in genetics : TIG.
[84] D. Vetrie,et al. Pelizaeus-Merzbacher disease: identification of Xq22 proteolipid-protein duplications and characterization of breakpoints by interphase FISH. , 1998, American journal of human genetics.
[85] K. Nave,et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. , 1998, Science.
[86] K. Nave,et al. Current concepts of PLP and its role in the nervous system , 1998, Microscopy research and technique.
[87] B. V. van Oost,et al. Duplication of the proteolipid protein gene is the major cause of Pelizaeus‐Merzbacher disease , 1998, Neurology.
[88] M. Klugmann,et al. Late‐onset neurodegeneration in mice with increased dosage of the proteolipid protein gene , 1998, The Journal of comparative neurology.
[89] H. Osaka,et al. An MRI and MRS study of Pelizaeus-Merzbacher disease. , 1998, Pediatric neurology.
[90] R. Lazzarini,et al. Disrupted Proteolipid Protein Trafficking Results in Oligodendrocyte Apoptosis in an Animal Model of Pelizaeus-Merzbacher Disease , 1998, The Journal of cell biology.
[91] M. Wegner,et al. Sox10, a Novel Transcriptional Modulator in Glial Cells , 1998, The Journal of Neuroscience.
[92] S. Timsit,et al. In situ expression of PLP/DM‐20, MBP, and CNP during embryonic and postnatal development of the jimpy mutant and of transgenic mice overexpressing PLP , 1997, Journal of Neuroscience Research.
[93] T. Lehner,et al. Pelizaeus-Merzbacher-like disease: Exclusion of the proteolipid protein locus and documentation of a new locus on Xq , 1997, Neurology.
[94] G. Paulson,et al. Family with Pelizaeus-Merzbacher disease/X-linked spastic paraplegia and a nonsense mutation in exon 6 of the proteolipid protein gene. , 1997, American journal of medical genetics.
[95] G. Kraft,et al. Proteolipid Protein Is Necessary in Peripheral as Well as Central Myelin , 1997, Neuron.
[96] J. Valk,et al. MRI assessment of myelination of motor and sensory pathways in the brain of preterm and term-born infants. , 1997, Neuropediatrics.
[97] M. Hodes,et al. Nonsense mutation in exon 3 of the proteolipid protein gene (PLP) in a family with an unusual form of Pelizaeus-Merzbacher disease. , 1997, American journal of medical genetics.
[98] J. Takanashi,et al. Proton MR spectroscopy in Pelizaeus-Merzbacher disease. , 1997, AJNR. American journal of neuroradiology.
[99] K. Nave,et al. Assembly of CNS Myelin in the Absence of Proteolipid Protein , 1997, Neuron.
[100] D. Colman,et al. Conservation of Topology, But Not Conformation, of the Proteolipid Proteins of the Myelin Sheath , 1997, The Journal of Neuroscience.
[101] K. Mikoshiba,et al. Myelin Proteolipid Protein (PLP), but Not DM-20, Is an Inositol Hexakisphosphate-binding Protein* , 1996, The Journal of Biological Chemistry.
[102] M. Nance,et al. Adult-onset neurodegenerative disorder due to proteolipid protein gene mutation in the mother of a man with Pelizaeus-Merzbacher disease , 1996, Neurology.
[103] R. Lazzarini,et al. A cellular mechanism governing the severity of Pelizaeus–Merzbacher disease , 1996, Nature Genetics.
[104] H. Osaka,et al. A duplicated PLP gene causing Pelizaeus-Merzbacher disease detected by comparative multiplex PCR. , 1996, American journal of human genetics.
[105] C. Campagnoni,et al. Expression of the myelin proteolipid protein gene in the human fetal thymus , 1996, Journal of Neuroimmunology.
[106] M. Yoshida,et al. Parallel Evolution and Coexpression of the Proteolipid Proteins and Protein Zero in Vertebrate Myelin , 1996, Neuron.
[107] K. Mikoshiba,et al. Cell death of oligodendrocytes or demyelination induced by overexpression of proteolipid protein depending on expressed gene dosage , 1996, Neuroscience Research.
[108] D. Barker,et al. Refined genetic mapping and proteolipid protein mutation analysis in X-linked pure hereditary spastic paraplegia , 1996, Neurology.
[109] E. Sistermans,et al. A (G-to-A) mutation in the initiation codon of the proteolipid protein gene causing a relatively mild form of Pelizaeus-Merzbacher disease in a Dutch family , 1996, Human Genetics.
[110] H. Osaka,et al. Novel nonsense proteolipid protein gene mutation as a cause of X-linked spastic paraplegia in twin males. , 1995, Biochemical and biophysical research communications.
[111] W. Stoffel,et al. Adhesive properties of proteolipid protein are responsible for the compaction of CNS myelin sheaths , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[112] F. Seitelberger. Neuropathology and Genetics of Pelizaeus‐Merzbacher Disease , 1995, Brain pathology.
[113] C. Readhead,et al. Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[114] I. Griffiths,et al. Expression of the proteolipid protein gene in glial cells of the post‐natal peripheral nervous system of rodents , 1995, Neuropathology and applied neurobiology.
[115] M. Hodes,et al. Girl with signs of Pelizaeus-Merzbacher disease heterozygous for a mutation in exon 2 of the proteolipid protein gene. , 1995, American journal of medical genetics.
[116] L. Puelles,et al. Oligodendrocytes originate in a restricted zone of the embryonic ventral neural tube defined by DM-20 mRNA expression , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[117] M. Dolivo,et al. Paralytic Tremor (pt): A New Allele of the Proteolipid Protein Gene in Rabbits , 1994, Journal of neurochemistry.
[118] W. Stoffel,et al. Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[119] L. Hudson,et al. A Combination of PLP and DM20 Transgenes Promotes Partial Myelination in the Jimpy Mouse , 1994, Journal of neurochemistry.
[120] K. Mikoshiba,et al. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene , 1994, Neuron.
[121] W. Richardson,et al. Embryonic expression of myelin genes: Evidence for a focal source of oligodendrocyte precursors in the ventricular zone of the neural tube , 1994, Neuron.
[122] K. Mikoshiba,et al. Fate of Jimpy‐Type Oligodendrocytes in Jimpy Heterozygote , 1994, Journal of neurochemistry.
[123] S. Malcolm,et al. Proteolipid protein gene dosage effect in Pelizaeus–Merzbacher disease , 1994, Nature Genetics.
[124] C. Readhead,et al. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage , 1994, Neuron.
[125] A. Munnich,et al. X–linked spastic paraplegia and Pelizaeus–Merzbacher disease are allelic disorders at the proteolipid protein locus , 1994, Nature Genetics.
[126] K. Kitagawa,et al. A proteolipid protein gene family: Expression in sharks and rays and possible evolution from an ancestral gene encoding a pore-forming polypeptide , 1993, Neuron.
[127] Yimin Yan,et al. Molecular cloning of M6: Identification of a PLP/DM20 gene family , 1993, Neuron.
[128] T. Weimbs,et al. Proteolipid protein (PLP) of CNS myelin: positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP. , 1992, Biochemistry.
[129] C. Campagnoni,et al. DM20 mRNA splice product of the myelin proteolipid protein gene is expressed in the murine heart , 1992, Journal of neuroscience research.
[130] K. Nave,et al. Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene , 1992, Nature.
[131] K. Mikoshiba,et al. Selective Expression of DM‐20, an Alternatively Spliced Myelin Proteolipid Protein Gene Product, in Developing Nervous System and in Nonglial Cells , 1992, Journal of neurochemistry.
[132] C. Williams,et al. Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. , 1991, American journal of human genetics.
[133] Karli M Nave,et al. Induction of the myelin proteolipid protein (PLP) gene in C6 glioblastoma cells: functional analysis of the PLP promotor , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[134] I. Griffiths,et al. Rumpshaker: an X‐linked mutation affecting CNS myelination. A study of the female heterozygote , 1991, Neuropathology and applied neurobiology.
[135] J. Popot,et al. Major myelin proteolipid: The 4-α-helix topology , 1991, The Journal of Membrane Biology.
[136] I. Duncan,et al. A point mutation in the proteolipid protein gene of the 'shaking pup' interrupts oligodendrocyte development. , 1990, Development.
[137] L. Hudson,et al. Conservative amino acid substitution in the myelin proteolipid protein of jimpymsd mice , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[138] M. Hodes,et al. Pelizaeus-Merzbacher disease: tight linkage to proteolipid protein gene exon variant. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[139] W. Stoffel,et al. Myelin‐deficient rat: a point mutation in exon III (A‐‐‐‐C, Thr75‐‐‐‐Pro) of the myelin proteolipid protein causes dysmyelination and oligodendrocyte death. , 1989, The EMBO journal.
[140] J. Berndt,et al. Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[141] Professor Dr. Jacob Valk,et al. Magnetic Resonance of Myelin, Myelination, and Myelin Disorders , 1989, Springer Berlin Heidelberg.
[142] R. Skoff,et al. Expression of the jimpy gene in the spinal cords of heterozygous female mice. 2. Oligodendroglial and endothelial cell hyperplasia. , 1989, Brain research. Developmental brain research.
[143] F. Bloom,et al. Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[144] F. Bloom,et al. Jimpy mutant mouse: a 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[145] R. Skoff,et al. Oligodendroglial cell death in jimpy mice: an explanation for the myelin deficit , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[146] R. Skoff,et al. Expression of the jimpy gene in the spinal cords of heterozygous female mice. I. An early myelin deficit followed by compensation , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[147] J. Aicardi,et al. Pelizaeus-Merzbacher Disease: Clinical and Nosological Study , 1986, Journal of child neurology.
[148] H. Willard,et al. Assignment of the gene for myelin proteolipid protein to the X chromosome: implications for X-linked myelin disorders. , 1985, Science.
[149] J. Rosenfeld,et al. Axonal swellings in jimpy mice: Does lack of myelin cause neuronal abnormalities? , 1983, Neuroscience.
[150] A. van Dorsselaer,et al. Brain proteolipids. Isolation, purification and effect on ionic permeability of membranes. , 1983, European journal of biochemistry.
[151] W. Demyer,et al. Pelizaeus-Merzbacher Disease , 2017 .
[152] V. McKusick,et al. A sex-linked recessive form of spastic paraplegia. , 1962, American journal of human genetics.
[153] L. Merzbacher. Eine eigenartige familiär-hereditäre erkrankungsform (Aplasia axialis extracorticalis congenita) , 1910 .
[154] Fr. Pelizaeus. Ueber eine eigenthümliche Form spastischer Lähmung mit Cerebralerscheinungen auf hereditärer Grundlage. (Multiple Sklerose) , 1885, Archiv für Psychiatrie und Nervenkrankheiten.
[155] A. Barkovich. Concepts of myelin and myelination in neuroradiology. , 2000, AJNR. American journal of neuroradiology.
[156] K. Woodward,et al. Prenatal diagnosis by FISH in a family with Pelizaeus-Merzbacher disease caused by duplication of PLP gene. , 1999, Prenatal diagnosis.
[157] W. Richardson,et al. Origins of spinal cord oligodendrocytes: possible developmental and evolutionary relationships with motor neurons. , 1997, Developmental neuroscience.
[158] PhD Marjo S. van der Knaap MD,et al. Magnetic Resonance of Myelin, Myelination, and Myelin Disorders , 1995, Springer Berlin Heidelberg.
[159] J. Berndt,et al. Identification of cis-regulatory elements in the myelin proteolipid protein (PLP) gene. , 1992, The Journal of biological chemistry.
[160] J. Popot,et al. Major myelin proteolipid: the 4-alpha-helix topology. , 1991, The Journal of membrane biology.
[161] D. Norman,et al. Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. , 1988, Radiology.
[162] D. Simon,et al. The structural gene coding for myelin-associated proteolipid protein is mutated in jimpy mice , 1986, Nature.